In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Message: IP
Generic_profile
Rank: [?]
Mail Room
Points: [?]
177
Rating: [?]
Votes: 3 Score: 3.0
  • Currently 3.0/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: IP

in response to IP by markak15
posted on Jan 23, 08 10:00AM

Since no one is answering my post...I will answer it myself.

 Mr. Lee says drug to polymer ratio is 1 to 4 versus 10-20, so less is better.  Also, cash supply is 18 months right now.  Burn less than 100K/month.

 I am impressed with the cash supply.  They should have a lot of significant news in the next 12 months, which should send the stock significantly higher before they need to raise cash again.

New Message

Please login to post a reply

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote